Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2013-04-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-013-1425-7PMID 23604173PMCID PMC11029704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity

  2013cited by this paper
• Glycobiology of immune responses

  2012cited by this paper
• Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.

  2012cited by this paper
• Two opposing roles of O-glycans in tumor metastasis.

  2012cited by this paper
• Epigenetic Silencing of the Chaperone Cosmc in Human Leukocytes Expressing Tn Antigen*

  2012cited by this paper
• The Tn Antigen—Structural Simplicity and Biological Complexity

  2011cited by this paper
• Microenvironment and Immunology Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy

  2011cited by this paper
• A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity.

  2011cited by this paper
• Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine.

  2009cited by this paper
• Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines

  2009cited by this paper
• Mucins in cancer: function, prognosis and therapy

  2009cited by this paper
• Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.

  2009cited by this paper
• Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies.

  2009cited by this paper
• A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell–lymphatic endothelium interaction

  2009cited by this paper
• The nature and sequence of the amino acid aglycone strongly modulates the conformation and dynamics effects of Tn antigen's clusters.

  2009cited by this paper
• Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo.

  2008cited by this paper
• Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.

  2008cited by this paper
• Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.

  2008cited by this paper
• Mucin-type O-glycosylation and its potential use in drug and vaccine development.

  2008cited by this paper
• Expression of CD175 (Tn), CD175s (sialosyl‐Tn) and CD176 (Thomsen‐Friedenreich antigen) on malignant human hematopoietic cells

  2008cited by this paper
• Serine versus threonine glycosylation: the methyl group causes a drastic alteration on the carbohydrate orientation and on the surrounding water shell.

  2007cited by this paper
• A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen

  2006cited by this paper
• Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions

  2006cited by this paper
• Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA?

  2006cited by this paper
• Glycosylation in cellular mechanisms of health and disease.

  2006cited by this paper
• Carbohydrate Array Analysis of Anti‐Tn Antibodies and Lectins Reveals Unexpected Specificities: Implications for Diagnostic and Vaccine Development

  2005cited by this paper
• Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.

  2005cited by this paper
• A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates

  2004cited by this paper
• MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology

  2004cited by this paper
• Mucins and mucin binding proteins in colorectal cancer

  2004cited by this paper
• Antifreeze glycoproteins: elucidation of the structural motifs that are essential for antifreeze activity.

  2004cited by this paper
• Development and characterization of an antibody directed to an α-N-acetyl-D-galactosamine glycosylated MUC2 peptide

  2004cited by this paper
• Detection of bone marrow‐disseminated breast cancer cells using an RT‐PCR assay of MUC5B mRNA

  2003cited by this paper
• Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma

  2003cited by this paper
• All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.

  2003cited by this paper
• A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase

  2002cited by this paper
• Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide-antibody interactions.

  2002cited by this paper
• Anti-Tumor Immunity Provided by a Synthetic Multiple Antigenic Glycopeptide Displaying a Tri-Tn Glycotope1

  2001cited by this paper
• Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues

  2001cited by this paper
• Database analysis of O-glycosylation sites in proteins.

  2001cited by this paper
• Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n‐acetylgalactosamine (GalNAc) peptides

  2000cited by this paper
• Analysis of the fine specificity of Tn‐binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy

  2000cited by this paper
• Validation of Tissue Microarray Technology in Breast Carcinoma

  2000cited by this paper
• Biochemical and functional characterization of the Tn-specific lectin from Salvia sclarea seeds.

  2000cited by this paper
• Tn antigen is a pre-cancerous biomarker in breast tissue and serum in n-nitrosomethylurea-induced rat mammary carcinogenesis.

  2000cited by this paper
• Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen.

  2000cited by this paper
• A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.

  1999cited by this paper
• Synthetic and Immunological Studies on Clustered Modes of Mucin‐Related Tn and TF O‐Linked Antigens: The Preparation of a Glycopeptide‐Based Vaccine for Clinical Trials Against Prostate Cancer.

  1999cited by this paper
• The acceptor specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases

  1999cited by this paper
• Synthetic and Immunological Studies on Clustered Modes of Mucin-Related Tn and TF O-Linked Antigens: The Preparation of a Glycopeptide-Based Vaccine for Clinical Trials against Prostate Cancer†

  1998cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• Development and characterization of an antibody directed to an alpha-N-acetyl-D-galactosamine glycosylated MUC2 peptide.

  1998cited by this paper
• MUC6 expression in breast tissues and cultured cells: Abnormal expression in tumors and regulation by steroid hormones

  1998cited by this paper
• Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes

  1997cited by this paper
• Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy

  1997cited by this paper
• Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study

  1996cited by this paper
• Blood‐Group Sialyl‐Tn Antigen Is More Specific than Tn as a Tumor Marker in the Pancreas

  1994cited by this paper
• Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128).

  1993cited by this paper
• Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen.

  1992cited by this paper
• Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps.

  1992cited by this paper
• Expression of Tn, sialosyl Tn, and T antigens in human pancreas.

  1991cited by this paper
• Production of a Monoclonal Antibody as Immunohistochemical Marker on Paraffin Embedded Tissues Using a New Immunization Method

  1990cited by this paper
• T and Tn, general carcinoma autoantigens.

  1984cited by this paper

• Diagnostic Potential of Tn-MUC1 in Breast Cancer: A Novel Immunohistochemical Marker Reflecting Tumor Progression.

  2026cites this paper
• GMMA decorated with mucin 1 Tn/STn mimetics elicit specific antibodies response and inhibit tumor growth

  2025cites this paper
• Exploring the Conformational Changes and Dynamics of Mucins in Their Free State and in Complex with Mucin-Binding Proteins Using NMR.

  2025cites this paper
• Mammalian cell-based production of glycans, glycopeptides and glycomodules

  2024cites this paper
• Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors

  2023cites this paper
• CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies

  2023cites this paper
• Identification of the glycopeptide epitope recognized by a protective Cryptosporidium monoclonal antibody

  2023influential citation
• The effect of a methyl group on structure and function: Serine vs. threonine glycosylation and phosphorylation

  2023cites this paper
• Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives

  2022cites this paper
• Antibody Diversity in Cancer: Translational Implications and Beyond

  2022cites this paper
• Lung Tumor Cells with Different Tn Antigen Expression Present Distinctive Immunomodulatory Properties

  2022cites this paper
• Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment

  2022cites this paper
• Research progress on O-GlcNAcylation in the occurrence, development, and treatment of colorectal cancer

  2021cites this paper
• A glycan-based plasmonic sensor for prostate cancer diagnosis.

  2021cites this paper
• Status Quo of Glycosylation in Cancer: What Is, What Is Not and What Is to Be

  2020cites this paper
• The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients

  2020cites this paper
• Chemical synthesis and immunological evaluation of new generation multivalent anticancer vaccines based on a Tn antigen analogue†

  2020cites this paper
• A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer

  2020cites this paper
• Identification of Tn Antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies.

  2019cites this paper
• Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitope.

  2019cites this paper
• Antibodies against aberrant glycans as cancer biomarkers

  2019cites this paper
• Water Sculpts the Distinctive Shapes and Dynamics of the Tumor-Associated Carbohydrate Tn Antigens: Implications for Their Molecular Recognition.

  2018cites this paper
• Design and synthesis of multivalent glycoconjugates for anti-cancer immunotherapy

  2017cites this paper
• Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.

  2017cites this paper
• Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides.

  2017cites this paper
• Epitope mapping of a new anti-Tn antibody detecting gastric cancer cells

  2017cites this paper
• Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines

  2017cites this paper
• Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate.

  2016cites this paper
• The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity

  2016cites this paper
• Glycoprotein screening in colorectal cancer based on differentially expressed Tn antigen.

  2016cites this paper
• Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen

  2016cites this paper
• Anticorps anti-muc16 et utilisations

  2016cites this paper
• The Quest for Anticancer Vaccines: Deciphering the Fine-Epitope Specificity of Cancer-Related Monoclonal Antibodies by Combining Microarray Screening and Saturation Transfer Difference NMR.

  2015cites this paper
• Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.

  2015cites this paper
• COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer

  2015cites this paper
• Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody**

  2015cites this paper
• Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43

  2014cites this paper
• Sweet and Sour: The Impact of Differential Glycosylation in Cancer Cells Undergoing Epithelial–Mesenchymal Transition

  2014cites this paper
• Serine versus threonine glycosylation with α-O-GalNAc: unexpected selectivity in their molecular recognition with lectins.

  2014cites this paper
• Biological Functions of C1GalT1 and Mucin-Type O-Glycans

  2014cites this paper
• Utilisation d'un anticorps monoclonal anti-Tn en immunothérapie des cancers

  2013cites this paper